PTC Therapeutics Inc 2024 SR
The report highlights PTC Therapeutics' 2024 achievements across five pillars: patients, people, community, environment, and governance. Key milestones include submitting four FDA approval applications and partnering with over 200 patient advocacy organizations globally. The company emphasized its One PTC culture through various employee resource groups and professional development programs. Environmental efforts focused on waste reduction, with New Jersey facilities recycling approximately 351 tons of material and the corporate headquarters sourcing over 20% of its electricity from wind power. Governance was strengthened through a robust Global Compliance Program and a multilayered cybersecurity risk management strategy.
Company: PTC Therapeutics Inc
Sector: Health Care
Country: United States
Year: 2024
Type: SR
Pages: 35
PTC Therapeutics Inc
Corporate Sustainability Report
The report highlights PTC Therapeutics' 2024 achievements across five pillars: patients, people, community, environment, and governance. Key milestones include submitting four FDA approval applications and partnering with over 200 patient advocacy organizations globally. The company emphasized its One PTC culture through various employee resource groups and professional development programs. Environmental efforts focused on waste reduction, with New Jersey facilities recycling approximately 351 tons of material and the corporate headquarters sourcing over 20% of its electricity from wind power. Governance was strengthened through a robust Global Compliance Program and a multilayered cybersecurity risk management strategy.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Renewable Energy
Women on Board